Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Mar;64(Suppl 2):ii42–ii45. doi: 10.1136/ard.2004.031567

Science of assessment

N Bellamy
PMCID: PMC1766886  PMID: 15708935

Abstract

Psoriatic arthritis is a multisystem disorder which, from a measurement standpoint, demands consideration of its cutaneous manifestations and both axial and peripheral musculoskeletal involvement. Measurements of various aspects of impairment, ability/disability, and participation/handicap are feasible using existing measurement techniques, which are for the most part valid, reliable, and responsive. Nevertheless, there remain opportunities for the further development of consensus around core set measures and responder criteria, as well as for instrument development and refinement, standardised assessor training, cross-cultural adaptation of health status questionnaires, electronic data capture, and the introduction of standardised quantitative measurement into routine clinical care.

Full Text

The Full Text of this article is available as a PDF (57.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman R., Brandt K., Hochberg M., Moskowitz R., Bellamy N., Bloch D. A., Buckwalter J., Dougados M., Ehrlich G., Lequesne M. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage. 1996 Dec;4(4):217–243. doi: 10.1016/s1063-4584(05)80101-3. [DOI] [PubMed] [Google Scholar]
  2. Beaton D. E., Bombardier C., Katz J. N., Wright J. G., Wells G., Boers M., Strand V., Shea B. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol. 2001 Feb;28(2):400–405. [PubMed] [Google Scholar]
  3. Bellamy N., Campbell J., Syrotuik J. Comparative study of self-rating pain scales in osteoarthritis patients. Curr Med Res Opin. 1999;15(2):113–119. doi: 10.1185/03007999909113371. [DOI] [PubMed] [Google Scholar]
  4. Bellamy N., Campbell J., Syrotuik J. Comparative study of self-rating pain scales in rheumatoid arthritis patients. Curr Med Res Opin. 1999;15(2):121–127. doi: 10.1185/03007999909113372. [DOI] [PubMed] [Google Scholar]
  5. Bellamy N., Kaloni S., Pope J., Coulter K., Campbell J. Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. J Rheumatol. 1998 May;25(5):852–858. [PubMed] [Google Scholar]
  6. Bellamy N., Kirwan J., Boers M., Brooks P., Strand V., Tugwell P., Altman R., Brandt K., Dougados M., Lequesne M. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997 Apr;24(4):799–802. [PubMed] [Google Scholar]
  7. Bellamy N., Muirden K. D., Brooks P. M., Barraclough D., Tellus M. M., Campbell J. A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol. 1999 Jul;26(7):1593–1599. [PubMed] [Google Scholar]
  8. Blackmore M. G., Gladman D. D., Husted J., Long J. A., Farewell V. T. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol. 1995 May;22(5):886–893. [PubMed] [Google Scholar]
  9. Clegg D. O., Reda D. J., Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum. 1999 Nov;42(11):2325–2329. doi: 10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  10. Clegg D. O., Reda D. J., Mejias E., Cannon G. W., Weisman M. H., Taylor T., Budiman-Mak E., Blackburn W. D., Vasey F. B., Mahowald M. L. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996 Dec;39(12):2013–2020. doi: 10.1002/art.1780391210. [DOI] [PubMed] [Google Scholar]
  11. Dougados M., Leclaire P., van der Heijde D., Bloch D. A., Bellamy N., Altman R. D. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage. 2000 Nov;8(6):395–403. doi: 10.1053/joca.2000.0361. [DOI] [PubMed] [Google Scholar]
  12. Duffy C. M., Watanabe Duffy K. N., Gladman D. D., Brubacher B. B., Buskila D., Langevitz P., Farewell V. T. The utility of the arthritis impact measurement scales for patients with psoriatic arthritis. J Rheumatol. 1992 Nov;19(11):1727–1732. [PubMed] [Google Scholar]
  13. Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993 Jun;36(6):729–740. doi: 10.1002/art.1780360601. [DOI] [PubMed] [Google Scholar]
  14. Felson D. T., Anderson J. J., Boers M., Bombardier C., Furst D., Goldsmith C., Katz L. M., Lightfoot R., Jr, Paulus H., Strand V. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995 Jun;38(6):727–735. doi: 10.1002/art.1780380602. [DOI] [PubMed] [Google Scholar]
  15. Felson D. T., Anderson J. J., Lange M. L., Wells G., LaValley M. P. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum. 1998 Sep;41(9):1564–1570. doi: 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  16. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  17. Gladman D. D., Farewell V., Buskila D., Goodman R., Hamilton L., Langevitz P., Thorne J. C. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol. 1990 Jan;17(1):62–64. [PubMed] [Google Scholar]
  18. Husted J. A., Gladman D. D., Cook R. J., Farewell V. T. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol. 1998 Nov;25(11):2146–2155. [PubMed] [Google Scholar]
  19. Husted J., Gladman D. D., Farewell V. T., Long J. A. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis. J Rheumatol. 1996 Jun;23(6):1015–1019. [PubMed] [Google Scholar]
  20. Husted J., Gladman D. D., Long J. A., Farewell V. T. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis. J Rheumatol. 1996 Nov;23(11):1932–1937. [PubMed] [Google Scholar]
  21. Pham Thao, Van Der Heijde Désirée, Lassere Marissa, Altman Roy D., Anderson Jennifer J., Bellamy Nicholas, Hochberg Marc, Simon Lee, Strand Vibeke, Woodworth Thasia. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol. 2003 Jul;30(7):1648–1654. [PubMed] [Google Scholar]
  22. Taccari E., Spadaro A., Rinaldi T., Riccieri V., Sensi F. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed. 1998 Dec;65(12):751–758. [PubMed] [Google Scholar]
  23. Ujfalussy I., Koó E. Measurement of disease activity in psoriatic arthritis. Extended report. Z Rheumatol. 2003 Feb;62(1):60–65. doi: 10.1007/s00393-003-0455-5. [DOI] [PubMed] [Google Scholar]
  24. van Tubergen A., van der Heijde D., Anderson J., Landewé R., Dougados M., Braun J., Bellamy N., Udrea G., van der Linden Sj. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis. 2003 Mar;62(3):215–221. doi: 10.1136/ard.62.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. van der Heijde D., Bellamy N., Calin A., Dougados M., Khan M. A., van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol. 1997 Nov;24(11):2225–2229. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES